• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Study: Children with asthma more likely to be prescribed unnecessary antibiotics

September 11, 2017 By Sarah Faulkner

PillsKids with asthma are more likely to be prescribed antibiotics, despite the fact that they don’t need them more than kids without asthma, according to a study that is slated to be presented at the European Respiratory Society International Congress.

Researchers from Erasmus University in the Netherlands pointed out that it’s possible that asthma symptoms are being mistaken for respiratory tract infections, leading healthcare worker to prescribe antibiotics. They also said it’s possible that antibiotics are being doled out to kids with asthma as a preventative measure.

“Asthma is a common and ongoing condition, and it has symptoms that could be mistaken for a respiratory tract infection. However, international and national guidelines clearly state that antibiotics should not be given for a deterioration in asthma symptoms, because this is rarely associated with a bacterial infection,” Dr. Esme Baan said in prepared remarks.

“Inappropriate use of antibiotics can be bad for individual patients and the entire population, and makes it harder to control the spread of untreatable infections.”

The study, which included 1.5 million kids in the U.K. and 375,000 from the Netherlands, compared antibiotic prescription data for kids with and without asthma.

The Netherlands and the U.K. adhere to the same international guidelines on asthma treatment, which recommend that antibiotics not be used to address exacerbations of the condition.

The team found that kids with asthma were 1.6 times more likely to be prescribed antibiotics compared to children without asthma. They also found that the antibiotic prescription rates were almost two-fold higher in the U.K.

In both places, amoxicillin was the most commonly-prescribed antibiotic, the researchers reported.

The Netherlands has low antibiotic use compared to the rest of the world, so the team hypothesized that the situation could be far worse in countries where antibiotic use is much higher – like Italy or Spain.

“Antibiotics should only be given when there is clear evidence of a bacterial infection such as for pneumonia. However, we saw that, in children with asthma, most of the antibiotic prescriptions in children were intended for asthma exacerbations or bronchitis, which are often caused by a virus rather than bacteria. It can be difficult for a GP to differentiate between a deterioration in asthma symptoms and a bacterial respiratory infection. We think this might be leading to more antibiotic prescriptions in children with asthma,” Baan added.

“Children with uncontrolled asthma can face difficulties over several years, for example it can affect their ability to play and take part in sport, they may have more days off school, or experience disturbed sleep. We don’t want to compound this with prescribing drugs that won’t help and may be harmful. Of course, sometimes antibiotics are needed, but we should be careful and only prescribe them when they are really required. In general, we should discourage GPs from prescribing unnecessary antibiotics or run the risk of more drug-resistant infections in the future.”

See the best minds in medtech live at DeviceTalks Boston on Oct. 2. 

Filed Under: Featured, Pharmaceuticals, Respiratory

IN CASE YOU MISSED IT

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Glucotrack can proceed with long-term glucose monitor study in Australia
  • Dexcom promotes Jake Leach to president role
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS